WallStreetZenWallStreetZen

NASDAQ: CRDL
Cardiol Therapeutics Inc Stock

$0.71+0.01 (+1.43%)
Updated Feb 3, 2023
CRDL Price
$0.71
Fair Value Price
N/A
Market Cap
$45.00M
52 Week Low
$0.47
52 Week High
$2.08
P/E
-2.16x
P/B
1.05x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$22.48M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.17
Operating Cash Flow
-$17M
Beta
1.55
Next Earnings
Mar 21, 2023
Ex-Dividend
N/A
Next Dividend
N/A

CRDL Overview

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses developing anti-fibrotic and anti-inflammatory therapies to treat cardiovascular disease. Its lead product is CardiolRx, which reduces cardiovascular and respiratory events in patients hospitalized with COVID-19. The company is also developing a subcutaneous formulation of CardiolRx to treat fibrosis and inflammation that progress to heart failure. Cardiol Therapeutics was incorporated in 2017 and is headquartered in Oakville, Ontario, Canada.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CRDL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CRDL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CRDL is good value based on its book value relative to its share price (1.05x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.9x)
P/B vs Industry Valuation
CRDL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CRDL due diligence checks available for Premium users.

Be the first to know about important CRDL news, forecast changes, insider trades & much more!

CRDL News

Valuation

CRDL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.16x
Industry
18.24x
Market
15.09x

CRDL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.05x
Industry
1.9x
CRDL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CRDL's financial health

Profit margin

Revenue
$0.0
Net Income
-$6.0M
Profit Margin
0%
CRDL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$51.8M
Liabilities
$7.3M
Debt to equity
0.17
CRDL's short-term assets ($49.46M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRDL's short-term assets ($49.46M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRDL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.7M
Investing
-$7.0k
Financing
-$10.5k
CRDL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CRDL vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
CRDL$45.00M+1.72%-2.16x1.05x
HUGE$44.21M+0.96%-2.69x1.68x
DERM$43.38M+9.38%-0.82x1.66x
TXMD$49.23M-0.95%-5.25x-1.02x
CPIX$37.46M-0.38%-5.51x0.97x

Cardiol Therapeutics Stock FAQ

What is Cardiol Therapeutics's quote symbol?

NASDAQ: CRDL) Cardiol Therapeutics trades on the NASDAQ under the ticker symbol CRDL. Cardiol Therapeutics stock quotes can also be displayed as NASDAQ: CRDL.

If you're new to stock investing, here's how to buy Cardiol Therapeutics stock.

What is the 52 week high and low for Cardiol Therapeutics (NASDAQ: CRDL)?

(NASDAQ: CRDL) Cardiol Therapeutics's 52-week high was $2.08, and its 52-week low was $0.47. It is currently -65.96% from its 52-week high and 49.68% from its 52-week low.

How much is Cardiol Therapeutics stock worth today?

(NASDAQ: CRDL) Cardiol Therapeutics currently has 63,562,778 outstanding shares. With Cardiol Therapeutics stock trading at $0.71 per share, the total value of Cardiol Therapeutics stock (market capitalization) is $45.00M.

Cardiol Therapeutics stock was originally listed at a price of $2.39 in Aug 10, 2021. If you had invested in Cardiol Therapeutics stock at $2.39, your return over the last 1 years would have been -70.38%, for an annualized return of -70.38% (not including any dividends or dividend reinvestments).

How much is Cardiol Therapeutics's stock price per share?

(NASDAQ: CRDL) Cardiol Therapeutics stock price per share is $0.71 today (as of Feb 3, 2023).

What is Cardiol Therapeutics's Market Cap?

(NASDAQ: CRDL) Cardiol Therapeutics's market cap is $45.00M, as of Feb 7, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cardiol Therapeutics's market cap is calculated by multiplying CRDL's current stock price of $0.71 by CRDL's total outstanding shares of 63,562,778.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.